Literature DB >> 18922890

MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions.

Sirigiri Divijendra Natha Reddy1, Kazufumi Ohshiro, Suresh K Rayala, Rakesh Kumar.   

Abstract

MicroRNAs are noncoding RNAs that inhibit the expression of their targets in a sequence-specific manner and play crucial roles during oncogenesis. Here we show that microRNA-7 (miR-7) inhibits p21-activated kinase 1 (Pak1) expression, a widely up-regulated signaling kinase in multiple human cancers, by targeting the 3'-untranslated region (UTR) of Pak1 mRNA. We noticed an inverse correlation between the levels of endogenous miR-7 and Pak1 expression in human cancer cells. We discovered that endogenous miR-7 expression is positively regulated by a homeodomain transcription factor, HoxD10, the loss of which leads to an increased invasiveness. HoxD10 directly interacts with the miR-7 chromatin. Accordingly, the levels of Pak1 protein are progressively up-regulated whereas those of miR-7 and its upstream activator HoxD10 are progressively down-regulated in a cellular model of breast cancer progression from low to highly invasive phenotypes. Furthermore, HoxD10 expression in highly invasive breast cancer cells resulted in an increased miR-7 expression but reduced Pak1 3'-UTR-luciferase activity and reduced Pak1 protein. Finally, we show that miR-7 introduction inhibits the motility, invasiveness, anchorage-independent growth, and tumorigenic potential of highly invasive breast cancer cells. Collectively, these findings establish for the first time that Pak1 is a target of miR-7 and that HoxD10 plays a regulatory role in modifying the expression of miR-7 and, consequently, the functions of the miR-7-Pak1 pathway in human cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922890      PMCID: PMC3636563          DOI: 10.1158/0008-5472.CAN-08-2103

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

Review 1.  Biology of the p21-activated kinases.

Authors:  Gary M Bokoch
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

Review 2.  Perspective: machines for RNAi.

Authors:  Yukihide Tomari; Phillip D Zamore
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

3.  A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye.

Authors:  Xin Li; Richard W Carthew
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

Review 4.  Nontransgenic models of breast cancer.

Authors:  G H Heppner; F R Miller; P M Shekhar
Journal:  Breast Cancer Res       Date:  2000-08-04       Impact factor: 6.466

5.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model.

Authors:  Meritxell Carrio; Gemma Arderiu; Connie Myers; Nancy J Boudreau
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

7.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

8.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

9.  Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes.

Authors:  Ratna K Vadlamudi; Rozita Bagheri-Yarmand; Zhibo Yang; Seetharaman Balasenthil; Diep Nguyen; Aysegul A Sahin; Petra den Hollander; Rakesh Kumar
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

10.  microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.

Authors:  Benjamin Kefas; Jakub Godlewski; Laurey Comeau; Yunqing Li; Roger Abounader; Michael Hawkinson; Jeongwu Lee; Howard Fine; E Antonio Chiocca; Sean Lawler; Benjamin Purow
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

View more
  125 in total

Review 1.  Regulation of mammalian microRNA expression.

Authors:  Xiaoxiao Zhang; Yan Zeng
Journal:  J Cardiovasc Transl Res       Date:  2010-02-20       Impact factor: 4.132

Review 2.  microRNAs: tiny RNA molecules, huge driving forces to move the cell.

Authors:  Shenglin Huang; Xianghuo He
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

3.  Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples.

Authors:  Mio Kitano; Reza Rahbari; Erin E Patterson; Seth M Steinberg; Nijaguna B Prasad; Yongchun Wang; Martha A Zeiger; Electron Kebebew
Journal:  Thyroid       Date:  2012-02-03       Impact factor: 6.568

Review 4.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

Review 5.  Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.

Authors:  Jeyanthy Eswaran; Da-Qiang Li; Anil Shah; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2012-05-17       Impact factor: 12.531

Review 6.  P21 activated kinases: structure, regulation, and functions.

Authors:  Chetan K Rane; Audrey Minden
Journal:  Small GTPases       Date:  2014-03-21

7.  miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.

Authors:  Hiroshi Okuda; Fei Xing; Puspa R Pandey; Sambad Sharma; Misako Watabe; Sudha K Pai; Yin-Yuan Mo; Megumi Iiizumi-Gairani; Shigeru Hirota; Yin Liu; Kerui Wu; Radhika Pochampally; Kounosuke Watabe
Journal:  Cancer Res       Date:  2013-02-05       Impact factor: 12.701

8.  Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7.

Authors:  Wentao Tang; Meiling Ji; Guodong He; Liangliang Yang; Zhengchuan Niu; Mi Jian; Ye Wei; Li Ren; Jianmin Xu
Journal:  Onco Targets Ther       Date:  2017-04-07       Impact factor: 4.147

9.  Prioritization of disease microRNAs through a human phenome-microRNAome network.

Authors:  Qinghua Jiang; Yangyang Hao; Guohua Wang; Liran Juan; Tianjiao Zhang; Mingxiang Teng; Yunlong Liu; Yadong Wang
Journal:  BMC Syst Biol       Date:  2010-05-28

10.  Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.

Authors:  Atsushi Kodama; Hiroki Sakai; Satoko Matsuura; Mami Murakami; Atsuko Murai; Takashi Mori; Kouji Maruo; Tohru Kimura; Toshiaki Masegi; Tokuma Yanai
Journal:  BMC Cancer       Date:  2009-10-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.